Spectral Medical Provides Update on Tigris Clinical Trial

Provides positive case study on patient enrolled at University of Michigan 14 clinical sites actively enrolling patients with 40 patients now randomized ...

Related Keywords

Japan ,United States ,Canada ,Toronto ,Ontario ,Michigan ,America ,Canadian ,Ali Mahdavi ,Chris Seto ,John Kellum ,Blair Mcinnis ,Kyle Gunnerson ,David Waldman Natalya Rudman ,Crescendo Communications ,Spectral Medical Inc ,Spinnaker Capital Markets Inc ,University Of Michigan ,Toronto Stock Exchange ,Dialco Medical Inc ,Health Canada ,Company Endotoxin Activity Assay ,Emergency Critical Care Center ,Dialco Medical ,Polymyxinb Hemoperfusion ,Tigris Trial Updates ,Chief Medical Officer ,Emergency Medicine Director ,Chief Executive Officer ,Breakthrough Device ,Endotoxin Activity Assay ,Breakthrough Device Designation ,North America ,